Cardiovascular calcification in nondialyzed patients with chronic kidney disease

Seminars in Dialysis

Volumn 20, Issue 2, 2007, Pages 134-138

  Qunibi, Wajeh Y ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCINOSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; HUMAN; METABOLISM; PATHOLOGY; PREDICTION AND FORECASTING; RENAL REPLACEMENT THERAPY; RISK FACTOR;

CALCINOSIS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; HUMANS; KIDNEY FAILURE, CHRONIC; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33947325525     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2007.00260.x     Document Type: Article

References (47)

1. United States Renal Data System. Annual Data Report. Bethesda, MD, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Division of Kidney, Urologie, and Hematologic Diseases, pp 339-348, 2000
2. El Nahas AM, Bello AK: Chronic kidney disease: the global challenge. Lancet 365:331-340, 2005
3. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton J, Lee Hamm L, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108:2154-2169, 2003
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296-1305, 2004
5. Keith DS, Nichols GA, Gullion CM, Brown JB, Smithet DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164:659-663, 2004
6. National Kidney Foundation: K/DOQI clinical practice guidelines for managing dyslipidemia in chronic kidney disease. Am J Kidney Dis 41(Suppl. 3):S1-S92, 2003
7. Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circulation 92:657-671, 1995
8. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V: Silent myocardial ischemia in patients with diabetes: Who to screen [see comments]. Diabetes Care 22:1396-1400, 1999
9. Chiariello M, Indolfi C: Silent myocardial ischemia in patients with diabetes mellitus [editorial; comment]. Circulation 93:2089-2091, 1996
10. Grover SA, Coupai L, Hu XP: Identifying adults at increased risk of coronary disease: How well do the current cholesterol guidelines work? JAMA 274:801-806, 1995
11. Wald NJ, Law M, Watt HC, Bailey A, Johnson AM, Craig WY, Ledue TE, Haddow JE: Apolipoproteins and ischemic heart disease: implications for screening. Lancet 343:75-79, 1994
12. Detrano R, Hsiai T, Wang S, Puentes G, Fallavollita J, Shields P, Stanford W, Wolfkiel C, Georgiou D, Budoff M, Reed J: Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography. J Am Coll Cardiol 27:285-290, 1996
13. Arad Y, Spadaro LA, Goodman K, Newstein D, Guerci AD: Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 36:1253-1260, 2000
14. Rumberger JA, Brundage BH, Rader DJ, Kondos G: Electron beam computed tomographic coronary artery calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 74:243-252, 1999
15. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft L: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394-401, 1997
16. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A. Greaser L, Elashoff RM. Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483, 2000
17. Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252, 2002
18. Virchow R: Kall metastasen. Virchows Arch Pathol Anat 8:103-113, 1855
19. Mulligan RM: Metastatic calcification. Arch Pathol 43:177-230, 1947
20. Meema HE, Oreopoulos DG, deVeber GA: Arterial calcifications in severe chronic renal disease and their relationship to dialysis treatment, renal transplant, and parathyroidectomy. Radiology 121:315-321, 1976
21. Kuzela DC, Huffer WE, Conger JD, Winter SD, Hammond AS: Soft tissue calcification in chronic dialysis patients. Am J Pathol 86:403-424, 1977
22. Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE: Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis. 44:1024-1030, 2004
23. Kramer H, Toto R, Peshock R, Victor R: Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study. J Am Sac Nephrol 16:507-513, 2005
24. Qunibi WY, Abouzahr F, Mizani MR, Nolan CR, Arya R, Hunt KJ: Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes. Kidney Int 68:271-277, 2005
25. Merjanian R, Budoff M, Adler S, Berman N, Mchrotra R: Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease. Kidney Int 64:263-271, 2003
26. Mehrotra R, Budoff M, Christenson P, Ipp E, Takasu J, Gupta A, Norris K, Adler S: Determinants of coronary artery calcification in diabetics with and without nophropathy. Kidney Int 66:2022-2031, 2004
27. Yoshida M, Takamatsu J, Yoshida S, Tanaka K, Takeda K, Higashi H, Kitaoka H, Ohsawa N: Scores of coronary calcification determined by electron beam computed tomography are closely related to the extent of diabetes-specific complications. Harm Metab Res 31:558-563, 1999
28. Wagenknecht LE, Bowden DW, Carr JJ, Langefeld CD, Freedman BI, Rich SS: Familial aggregation of coronary artery calcium in families with type 2 diabetes Diabetes 50:861-866, 2001
29. Edmonds ME, Morrison N, Laws JW, Watkins PJ: Medial arterial calcification and diabetic neuropathy. Br Med J (Clin Res Ed) 284:928-930, 1982
30. Psyrogiannis A, Kyriazopoulou V, Vagenakis AG: Medial arterial calcification is frequently found in patients with microalbuminuria. Anglology 50:971-975, 1999
31. Mehrotra R, Budoff M, Hokanson JE, Ipp E, Takasu J, Adler S: Progression of coronary artery calcification in diabetics with and without chronic kidney disease. Kidney Int 68:1258-1266, 2005
32. Qunibi WY, Nolan CR, Ayus JC: Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon. Kidney Int 82:(Suppl.):73-80, 2002
33. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208-2218, 2004
34. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Moni H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:e10-e17, 2000
35. Block GA, Speigel DM, Ehrlich J, Mehta R, Lindbergh J, Dreishbach A, Raggi P: Effects of sevelamer and calcium on coronary artery calcification in patients new to dialysis. Kidney Int 68:1815-1824, 2005
36. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ: Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339:1972-1978, 1998
37. Aehenbach S, Ropers D, Pohle K. Leber A, Thilo C, Knez A, Menendez T, Maeffert R, Kusus M, Regenfus M, Bickel A, Haberl R, Steinbeck G, Moshage W, Daniel WG: Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation 106:1077-1082, 2002
38. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH: Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 51:1157-1165, 2002
39. Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellilus. Lancet 340:319, 1992
40. Shilpak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracey RP, Furberg CD, Psaty BM: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107:87-92, 2003
41. Kelleler M, Bongarlz P, Westenfeld R, Wildberger JE, Mahnken AH, Böhm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361:827-833, 2003
42. Hujairi NM, Afzali B, Goldsmith DJ: Cardiac calcification in renal patients: what we do and don't know. Am J Kidney Dis 43:234-243, 2004
43. Mehrotra R, Westenfeld R, Christenson P, Budoff M, Ipp E, Takasu J, Gupta A, Norris K, Kettler M, Adler S: Serum fetuin-A in nondialyzed patients with diabetic nephropalhy: relationship with coronary artery calcification. Kidney Int 67:1070-1077, 2005
44. Moe SM, Reslerova M, Ketteler M, O'Neill K, Duan D, Koczman J, Weslerfeld R, Jahnen-Dechent W, Chen NX: Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 67:2295-2304, 2005
45. Price PA, Caputo JM, Williamson MK: Bone origin of the serum complex of calcium, phosphate, fetuin, and matrix Gla protein: biochemical evidence for the cancellous bone-remodeling compartment. J Bone Miner Res 17:1171-1179, 2002
46. Price PA, Williamson MK, Nguyen TM, Than TN: Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J Biol Chem 279:1594-1600, 2004
47. Nitta K, Akiba T, Uchida K, Otsubo S, Takei T, Yumura W, Kabaya T, Nihei H: Serum osteoprotegerin levels and the extent of vascular calcification in hemodialysis patients. Nephrol Dial Transplant 19:1886-1889, 2004